Bryn Mawr Capital Management LLC Takes $694,000 Position in Teleflex Incorporated (NYSE:TFX)

Bryn Mawr Capital Management LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,900 shares of the medical technology company’s stock, valued at approximately $694,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Cromwell Holdings LLC grew its holdings in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after buying an additional 49 shares during the last quarter. Avior Wealth Management LLC grew its holdings in Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in Teleflex during the 3rd quarter valued at $40,000. True Wealth Design LLC grew its holdings in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new stake in Teleflex during the 3rd quarter valued at $54,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Trading Up 0.2 %

Shares of TFX opened at $175.43 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $8.15 billion, a P/E ratio of 34.88, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. The stock’s fifty day simple moving average is $177.07 and its 200 day simple moving average is $207.80. Teleflex Incorporated has a twelve month low of $165.62 and a twelve month high of $249.90.

Analyst Ratings Changes

A number of brokerages have commented on TFX. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Royal Bank of Canada reduced their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Mizuho reduced their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Finally, Truist Financial reduced their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.